By choosing Tisch MSRCNY as your charitable recipient on Amazon Smile, Amazon will donate to our laboratory at no additional cost to you. To shop with Amazon Smile, go to smile.amazon.com and type in Tisch MS Research Center of New York.
Tisch MSRCNY will be hosting its 23 rd annual patient symposium. Registration is open for the FREE educational event, held at the New York Hilton Midtown on Sunday, March 19th, 2023. Patients, their families, and caregivers are all welcome to attend. To register, click here.
Tisch MSRCNY wishes everyone a joyous holiday season! We will be closed on Friday, December 23rd, and we will reopen on Tuesday, December 27th at 9:00 AM. Additionally, we will be closed on January 2nd and reopen on January 3rd at 9:00 AM.
As the year concludes, we are excited to share the impact Tisch MSRCNY has had in 2022, thanks to our dedicated team and each of our generous supporters.
On Friday, our researchers and physicians discussed a paper comparing the gut microbiome of MS patients to healthy household controls. Changes in the gut microbiome have been associated with several diseases. The authors of this paper aimed to identify and investigate alterations to the gut...
Today is #GivingTuesday . Please consider making a contribution to Tisch MS Research Center of New York, as we strive to create a #FuturewithoutMS . https://www.tischms.org/donate
Last week, Tisch MSRCNY researchers attended the Society for Neuroscience (SfN) . Neuroscientists from around the world joined together in San Diego, where they discussed, shared and discovered new ideas in research. Dr. Jamie Wong, Dr. Nicolas Daviaud, Rose Griffin, Ivy Gao, and Jiayuan Lin...
Happy Thanksgiving from everyone at Tisch MSRCNY! Our office will be closed for the holiday beginning today, November 23rd at 1:00 PM, and will reopen on Monday, November 28th at 9:00 AM. Wishing everyone a safe and happy holiday!
On Friday, our researchers and physicians discussed a paper that aimed to identify early neurodegenerative pathways in progressive MS. MS is an autoimmune disease that typically presents as a relapsing-remitting course, followed by a progressive phase. Researchers aimed to understand the molecular...